Embecta (EMBC) EBITDA Margin (2020 - 2026)
Embecta (EMBC) posted EBITDA Margin of 22.78% for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 13.02 percentage points from 35.80% a year earlier but up 1.23 percentage points from the prior quarter.
Embecta (EMBC) EBITDA Margin (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Embecta was 27.30%, up 3.79 percentage points year-over-year; for FY2025 (ended Sep 30, 2025), it came in at 27.14%, up 8.50 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of -21.21 percentage points (FY2020 to FY2025).
- In prior fiscal years, Embecta's EBITDA Margin was 18.64% in FY2024 (-4.04 pp), 22.67% in FY2023 (-7.55 pp), 30.22% in FY2022 (-15.29 pp) and 45.51% in FY2021 (-2.84 pp).
- Quarterly EBITDA Margin has run from a low of 1.64% in fiscal Q4 2022 to a high of 43.21% in fiscal Q1 2022 over five years.
- On a year-over-year basis, EBITDA Margin increased in five of the last eight quarters, with an average year-over-year change of +4.32 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was fiscal Q1 2026, with a gain of 21.33 percentage points; the weakest was fiscal Q4 2022, with a drop of 40.28 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior fiscal quarters was 21.55% (Q2 2026), 36.83% (Q1 2026) and 27.35% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 265.71 Bn | 242.23 Bn | 5.13 Bn | 25.44% |
| 2 | Abbott Laboratories | 189.37 Bn | 163.23 Bn | 7.39 Bn | 20.09% |
| 3 | Danaher | 164.78 Bn | 144.43 Bn | 3.84 Bn | 30.00% |
| 4 | Intuitive Surgical | 157.85 Bn | 138.13 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 129.66 Bn | 94.91 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 121.82 Bn | 108.01 Bn | 4.25 Bn | 20.38% |
| 7 | Boston Scientific | 63.42 Bn | 58.86 Bn | 3.43 Bn | 23.14% |
| 8 | Edwards Lifesciences | 59.49 Bn | 42.69 Bn | 1.35 Bn | 20.05% |
| 9 | Becton Dickinson | 58.38 Bn | 55.53 Bn | 2.32 Bn | 24.62% |
| 10 | Embecta | 365.49 Mn | -460.91 Mn | 153.30 Mn | 22.78% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.78% |
| Mar 31, 2026 | 21.55% |
| Dec 31, 2025 | 36.83% |
| Sep 30, 2025 | 27.35% |
| Jun 30, 2025 | 35.80% |
| Mar 31, 2025 | 28.80% |
| Dec 31, 2024 | 15.50% |
| Sep 30, 2024 | 13.21% |
| Jun 30, 2024 | 24.59% |
| Mar 31, 2024 | 17.20% |
| Dec 31, 2023 | 20.16% |
| Sep 30, 2023 | 13.02% |
| Jun 30, 2023 | 20.76% |
| Mar 31, 2023 | 22.95% |
| Dec 31, 2022 | 35.40% |
| Sep 30, 2022 | 2.11% |
| Jun 30, 2022 | 37.10% |
| Mar 31, 2022 | 38.51% |
| Dec 31, 2021 | 43.21% |
| Sep 30, 2021 | 41.92% |
Embecta EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EMBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "EMBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EMBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();